Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Ultra-low dose of alcohol (1 ml) is still effective

Heart and Vessels

Volumn 24, Issue 1, 2009, Pages 27-31

  Veselka, Josef ^a   Zemánek, David ^a   Tomašov, Pavol ^a   Duchoňová, Radka ^a   Linhartová, Kateřina ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Ablation; Hypertrophic cardiomyopathy; Obstruction; Therapy

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE RESPONSE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; INJECTIONS, INTRALESIONAL; MIDDLE AGED; MYOCARDIUM; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59049084482     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1083-4     Document Type: Article

References (23)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, ten Cate FJ, Wigle ED (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic cardiomyopathy. Eur Heart J 24:1965-1991
2. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232-2239
3. Sigwart U (1995) Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 346:211-214
4. Faber L, Seggewiss H, Welge D, Fassbender D, Schmidt HK, Gleichmann U, Horstkotte D (2004) Echo-guided percutaneous septal ablation for symptomatic hypertrophic cardiomyopathy: 7 years of experience. Eur J Echocardiogr 5:347-355
5. Alam M, Dokainish H, Lakkis N (2006) Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. A systematic review of literature. J Intervent Cardiol 19:319-327
6. Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM (2006) Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J 27:1805-1810
7. van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Gotte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC (2005) Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111:2503-2508
8. Veselka J (2007) Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A review of the literature. Med Sci Monit 13:RA62-RA68
9. Veselka J, Procházkov́ Š., Duchoňová R, Bolomová-Homolovř I, Tesař D (2005) Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: A mid-term follow-up. Echocardiography 22:105-11
10. Veselka J, Duchoňová R, Procházková Š, Páleníčková J, Sorajja P, Tesař D (2005) Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes. Am J Cardiol 95:675-6
11. Cheng TO (2004) Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: How much alcohol should be injected? Catheter Cardiovasc Interv 65:313-314
12. Veselka J, Duchoňová R, Páleníčková J, Zemánek D, Tišerová M, Linhartová K, Červinka P (2006) Impact of ethanol dosing on long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A single-center, prospective, and randomized study. Circ J 70:1550-1552
13. La Canna G, Airoldi F, Capritti E, Grimaldi A, Colombo A, Alfieri O (2007) Alcohol septal ablation versus surgical myectomy: A patient with obstructive HCM. Nature Clin Pract Cardiovasc Med 4:570-576
14. Efthimiadis GK. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: Improving cardiac function by generating a myocardial scar. Eur Heart J 2007; 28:1270-1271
15. Maron BJ (2000) Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 355:425-426
16. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA (2004) The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44:2044-2053
17. Fifer MA (2007) Most fully informed patients choose septal ablation over septal myectomy. Circulation 116:207-216
18. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK (1996) Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94:467-471
19. Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK (2007) Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy-the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med 4:503-512
20. Veselka J (2007) Alcohol septal ablation: Focus on safety. Swiss Med Wkly 137:657-659
21. Angelini P (2007) The "1st septal unit" in hypertrophic obstructive cardiomyopathy. Tex Heart Inst J 34:336-346
22. Sumimoto T, Hamada M, Ohtani T, Shigematsu Y, Fujiwara Y, Sekiva M, Hiwada K (1992) A large conus artery in patients with hypertrophic cardiomyopathy. Heart Vessels 7:52-55
23. Efthimiadis GK, Hitoglou-Makedou A, Giannakoulas G, Mitakidou A, Karamitsos T, Karvounis H, Mochlas S, Styliadis I, Stefanidis H (2007) Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy. Heart Vessels 22:322-327